{"id":"placebo-of-tqc2731","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL3770173","moleculeType":"Small molecule","molecularWeight":"440.32"},"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"As a placebo, this formulation is pharmacologically inert and serves as a control comparator in the phase 3 clinical trial of TQC2731. It allows for assessment of the true efficacy and safety of the active drug by comparison against a non-active treatment.","oneSentence":"This is a placebo control arm and contains no active pharmaceutical ingredient.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:28:18.514Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07107256","phase":"PHASE3","title":"Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps","status":"RECRUITING","sponsor":"Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.","startDate":"2025-09-25","conditions":"Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)","enrollment":246},{"nctId":"NCT06707883","phase":"PHASE2","title":"A Clinical Study of TQC2731 Injection in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.","startDate":"2024-12-31","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":258},{"nctId":"NCT05472324","phase":"PHASE2","title":"Evaluate the Efficacy and Safety of TQC2731 Injection in Patients With Severe Asthma.","status":"COMPLETED","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2022-09-23","conditions":"Severe Asthma","enrollment":205},{"nctId":"NCT06036927","phase":"PHASE2","title":"A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal Polyps","status":"COMPLETED","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2023-12-08","conditions":"Chronic Sinusitis, Nasal Polyps","enrollment":80},{"nctId":"NCT06829784","phase":"PHASE3","title":"TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection","status":"RECRUITING","sponsor":"Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.","startDate":"2025-03-21","conditions":"Asthma","enrollment":660},{"nctId":"NCT04923607","phase":"PHASE1","title":"Phase I Clinical Trial of TQC2731 Injection","status":"UNKNOWN","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2021-06-25","conditions":"Asthma Severe Persistent Controlled","enrollment":96}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo of TQC2731","genericName":"Placebo of TQC2731","companyName":"Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.","companyId":"shanghai-chia-tai-tianqing-pharmaceutical-technology-development-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}